Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
The optimal clinical management of patients with antiphospholipid antibody syndrome (APS) is uncertain because of a lack of an underlying hypothesis to explain why antiphospholipid autoantibodies (aPL) form to such ubiquitous compounds as phospholipids (PL). In this paper, we demonstrate that many,...
Na minha lista:
| 發表在: | J Clin Invest |
|---|---|
| Principais autores: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
1996
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507492/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8698874/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118854 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
